Omicron's edge: boosters pressure SARS-CoV-2 to adapt and evolve

Brasil Notícia Notícia

Omicron's edge: boosters pressure SARS-CoV-2 to adapt and evolve
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 62 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 28%
  • Publisher: 71%

The effects of vaccine booster doses on the adaptive evolution of the virus.

By Dr. Priyom Bose, Ph.D.Oct 25 2023Reviewed by Lily Ramsey, LLM Viruses naturally adapt to positive and negative environmental pressures, such as natural or vaccine-induced active immunity or passive immunity mediated by the transfer of antibodies from another individual.

This phenomenon has been held responsible for the rapid spread and high rate of breakthrough infections with Omicron. Such convergent mutations occur against an increasing but incomplete antibody response that cannot neutralize a rapidly evolving virus. This drives the appearance of common or recurrent mutations in different strains.

In this case, Omicron rapidly became dominant and has continued to spread and change until the present day. Related StoriesThis was conducted for each variant of the virus, categorizing each shift by the vaccine status of the individual, the ancestral descent of the viral strain, and the demographic and clinical characteristics of the participants.

Interestingly, the first booster doses were rolled out on a large scale during the Delta wave, but almost all subsequent breakthrough infections and reinfections were caused by the Omicron variant. These, however, poorly adapted the virus to spread or survive neutralizing antibodies – diffuse adaptive evolution.

High negative selection scores were observed with Omicron BA.2-BA.5, but not Delta or BA.1, indicating the rejection of multiple mutations so that the wildtype sequence was restored at those sites.

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

NewsMedical /  🏆 19. in UK

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Estimating hospital-acquired SARS-CoV-2 infections in EnglandEstimating hospital-acquired SARS-CoV-2 infections in EnglandAn estimated 95,000–167,000 inpatients at English National Health Service (NHS) hospitals caught SARS-CoV-2 while in hospital during England's 'second wave' of COVID-19, between June 2020 and March 2021, reports a paper, 'The burden and dynamics of hospital-acquired SARS-CoV-2 in England,' published in Nature.
Consulte Mais informação »

New research aims to understand the ecology of SARS-CoV-2 at the human-animal interfaceNew research aims to understand the ecology of SARS-CoV-2 at the human-animal interfaceAt the height of the COVID-19 pandemic, Virginia Tech disease ecologists wondered if the virus was having the same effect on wildlife.
Consulte Mais informação »

Viral rebound and safety of nirmatrelvir/ritonavir for lung-transplant recipients infected with SARS-CoV-2Viral rebound and safety of nirmatrelvir/ritonavir for lung-transplant recipients infected with SARS-CoV-2Data on the viral rebound and safety of nirmatrelvir/ritonavir in lung transplant (LTx) recipients are limited. A study published in Biosafety and Health prospectively followed four LTx recipients. Clinical characteristics, viral RNA dynamic in throat swabs, and tacrolimus blood concentration were monitored regularly.
Consulte Mais informação »

Community immunity: Steering the evolutionary course of SARS-CoV-2Community immunity: Steering the evolutionary course of SARS-CoV-2Researchers in Germany have developed a comprehensive fitness model that forecasts the evolution of SARS-CoV-2 by integrating genetic, epidemiological, and immunological data. The study emphasizes the role of population immunity in shaping viral mutations and provides valuable insights into the emergence of new variants.
Consulte Mais informação »

Weakened innate immunity may increase risk of severe COVID-19Weakened innate immunity may increase risk of severe COVID-19During severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, activated macrophages, dendritic cells, neutrophils, and natural killer cells are the first defense against infection.
Consulte Mais informação »

Kids with Omicron non-infectious after three days, vaccination status irrelevantKids with Omicron non-infectious after three days, vaccination status irrelevantStudy found that the median duration of infectivity for the Omicron variant of SARS-CoV-2 in children is three days, regardless of vaccination status. The findings suggest that current 5-day isolation policies are supported, but vaccination or booster status need not be considered in return-to-school guidelines.
Consulte Mais informação »



Render Time: 2025-02-26 17:50:28